Table 3.
Interventions (above) and outcomes (below).
| Number of services (%) | |
|---|---|
| Interventions | |
| Non-pharmacological interventions (not mutually exclusive) | 37 |
| Clinical monitoring | 37 (100.0) |
| Psychoeducation | 30 (81.1%) |
| Case management and psychosocial supporta | 27 (73.0) |
| Family interventionb | 27 (73.0) |
| CBT-based individual interventionc | 25 (67.6) |
| Other individual psychotherapeutic interventiond | 24 (64.9) |
| Physical health interventionse | 14 (37.8) |
| Group social or therapeutic interventionsf | 7 (18.9) |
| Pharmacological interventions (not mutually exclusive) | 31 |
| Antipsychotic medication | 27 (87.1) |
| Antidepressants | 23 (74.2) |
| Anxiolytics | 16 (51.6) |
| Mood stabilizers | 12 (38.7) |
| Omega-3 fatty acids | 3 (9.7) |
| Duration of service provision | 29 |
| 6 months | 1 (3.4) |
| 12 months | 7 (24.1) |
| 24 months | 13 (44.8) |
| 36 months | 3 (10.3) |
| 60 months or more | 5 (17.2) |
| Outcomes | |
| Type of outcomes (not mutually exclusive) | 43 |
| Persistence of symptoms/comorbidities | 29 (67.4) |
| Transition to psychosis | 23 (53.5) |
| Functional status | 21 (48.8) |
| Remission | 18 (41.9) |
| Physical health outcomes | 13 (30.2) |
| Service users’ satisfaction | 11 (25.6) |
| Hospitalisation | 8 (18.6) |
| Mortality | 6 (13.9) |
| Outcome instruments (not mutually exclusive) | 43 |
| Clinical interviews | 40 (93.0) |
| Psychometric instruments | 16 (37.2) |
| CAARMS | 10 (23.2) |
| SIPS | 5 (11.6) |
| Electronic health records | 7 (16.3) |
For footnotes see the supplementary section (eResults 2).